Market Reviews

Trauma players Acumed, Amplitude Surgical and Paragon 28 are likely to be positively impacted by Stryker's purchase of Wright Medical.

The fourth quarter of 2020 brought a dramatic surge in the pandemic that further depressed orthopedic surgical volumes worldwide.

The orthopedic industry faced unique challenges and profound uncertainty in 2020. We recap market's recovery through nine months and our 2020 projections.

A look into three companies outside the U.S. in the $100 million to $300 million revenue bracket: LimaCorporate, Medartis and AK Medical.

While the orthopedic market recovered faster than expected in the second quarter, we saw indications of deceleration heading into the third quarter.

The orthopedic market recovery rate accelerated in 2Q and delivered better results than expected, but questions about the new patient pipeline remain.

We expect 2Q20 orthopedic performance above consensus projections, but the U.S.'s inability to check the spread of COVID-19 will slow market recovery.

Increasing adoption of enabling technology, company consolidation through M&A, and accelerating growth of outpatient centers are COVID-proof orthopedic trends that will shape the market in 2021 and beyond.

Despite the uncertainty brought on by COVID-19, we've looked ahead and developed our orthopedic market forecast and trends through 2022.

Patient sentiment and confidence will play a key role in the COVID-19 orthopedic procedure recovery. What can we learn about patients from the data?